申请人:Merck & Co., Inc.
公开号:US06432981B1
公开(公告)日:2002-08-13
The present invention is directed to compounds of the formula I:
(wherein R1, R2, R3, R4, R5, R7, R8, X, n, x and y are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.
本发明涉及式I的化合物:(其中R1、R2、R3、R4、R5、R7、R8、X、n、x和y在此处定义),这些化合物可作为趋化因子受体活性的调节剂。具体而言,这些化合物可作为趋化因子受体CCR-5和/或CCR-3的调节剂。